<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="editorial">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">q9nwfxbVqhnM3vggb3xcqHg</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2013000100002</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(13)10000100002</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2013000100002</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Editorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sociedade Brasileira de Cardiologia: carta do Rio de Janeiro - III Brasil Prevent / I Am&#233;rica Latina Prevent</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Andrade</surname>
            <given-names>Jadelson P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arnett</surname>
            <given-names>Donna K.</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinto</surname>
            <given-names>Fausto</given-names>
          </name>
          <xref ref-type="aff" rid="aff04"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pi&#241;eiro</surname>
            <given-names>Daniel</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Smith Jr</surname>
            <given-names>Sidney C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff05"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mattos</surname>
            <given-names>Luiz Alberto P.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Machado</surname>
            <given-names>Carlos Alberto</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Gl&#225;ucia Maria M.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dohmann</surname>
            <given-names>Hans F.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gielen</surname>
            <given-names>Stephan</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="aff05">
        <institution content-type="orgname">World Heart Federation</institution>
        <country country="CH">Switzerland</country>
      </aff>
      <aff id="aff01">
        <institution content-type="orgname">Sociedade Brasileira de Cardiologia</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff04">
        <institution content-type="orgname">European Society of Cardiology</institution>
        <country country="BE">Belgium</country>
      </aff>
      <aff id="aff03">
        <institution content-type="orgname">American Heart Association</institution>
        <country country="US">USA</country>
      </aff>
      <aff id="aff02">
        <institution content-type="orgname">American Heart Association</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>01</month>
        <year>2013</year>
      </pub-date>
      <volume>100</volume>
      <issue>1</issue>
      <fpage>3</fpage>
      <lpage>5</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <pub-date publication-format="electronic" date-type="pub">
        <day>29</day>
        <month>01</month>
        <year>2013</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>EDITORIAL</bold>
    </p>
    <p>
      <bold>Sociedade Brasileira de Cardiologia : carta do Rio de Janeiro - III Brasil Prevent / I Am&#233;rica Latina Prevent</bold>
    </p>
    <p>
      <bold>Jadelson P. Andrade; Donna K. Arnett; Fausto Pinto; Daniel Pi&#241;eiro; Sidney C. Smith Jr; Luiz Alberto P. Mattos; Carlos Alberto Machado; Gl&#225;ucia Maria M. Oliveira; Hans F. Dohmann; Stephan Gielen</bold>
    </p>
    <p>
      <bold>Objetivo</bold>
    </p>
    <p>O documento final ser&#225; publicado como artigo especial nos Arquivos Brasileiros de Cardiologia e como editorial nas revistas cient&#237;ficas das sociedades m&#233;dicas e suas afiliadas que apoiam este documento. </p>
    <p>O documento tem como objetivo fornecer uma vis&#227;o geral das doen&#231;as cardiovasculares e tra&#231;ar a&#231;&#245;es estrat&#233;gicas para reduzir a preval&#234;ncia de fatores de risco que contribuem para a alta mortalidade e morbidade. </p>
    <p>Levando em considera&#231;&#227;o a Declara&#231;&#227;o Pol&#237;tica da Reuni&#227;o de Alto N&#237;vel das Na&#231;&#245;es Unidas sobre Preven&#231;&#227;o e Controle das Doen&#231;as N&#227;o Transmiss&#237;veis (DCNT)<sup>1</sup>. </p>
    <p>Referendando a meta global de redu&#231;&#227;o de 25% na mortalidade precoce por doen&#231;as n&#227;o transmiss&#237;veis at&#233; 2025<sup>1</sup>, estabelecida na Assembleia Mundial de Sa&#250;de (WHA) 65,8, em conson&#226;ncia com a Reuni&#227;o de Alto N&#237;vel das Na&#231;&#245;es Unidas sobre Preven&#231;&#227;o e Controle das DCNT, </p>
    <p>Reconhecendo que, em 2008, 36 milh&#245;es (63%) das mortes globais foram causadas por DCNT, das quais 9 milh&#245;es ocorreram antes dos 60 anos de idade e que, al&#233;m disso, quase 80% das principais doen&#231;as cr&#244;nicas (29 milh&#245;es) ocorreram em pa&#237;ses de baixa e m&#233;dia renda, </p>
    <p>Reconhecendo, finalmente, que as doen&#231;as cardiovasculares continuar&#227;o sendo a principal causa de morte no mundo, cerca de 7,3 milh&#245;es/ano, n&#250;mero que dever&#225; superar 23,6 milh&#245;es at&#233; 2030<sup>2</sup>, especialmente na Am&#233;rica Latina, onde cerca de 40% das mortes ocorrem durante os anos mais produtivos de vida<sup>3</sup>. </p>
    <p>No Brasil, as DCNT s&#227;o um problema de sa&#250;de de grande magnitude, correspondendo a 72% das causas de morte, especialmente doen&#231;as cardiovasculares (31,3%), c&#226;ncer (16,3%), doen&#231;as respirat&#243;rias cr&#244;nicas (5,8%) e diabetes (5,2%), afetando indiv&#237;duos de todos os n&#237;veis socioecon&#244;micos e, mais especificamente, aqueles que pertencem a grupos vulner&#225;veis, como os idosos e as pessoas com baixo n&#237;vel educacional e econ&#244;mico<sup>3</sup>. </p>
    <p>No Brasil, 300 mil morrem anualmente devido a doen&#231;as cardiovasculares, como infarto, acidente vascular encef&#225;lico, insufici&#234;ncias card&#237;aca e renal ou morte s&#250;bita, o que significa 820 mortes por dia, 30 mortes por hora ou uma morte a cada 2 minutos<sup>3</sup>.</p>
    <p>Estima-se que a redu&#231;&#227;o de 10% da taxa de mortalidade causada por doen&#231;a isqu&#234;mica do cora&#231;&#227;o e acidente vascular encef&#225;lico geraria uma economia estimada em US$ 25 bilh&#245;es por ano para os pa&#237;ses de baixa e m&#233;dia renda<sup>4,5</sup>. </p>
    <p>&#201; amplamente conhecido o papel das sociedades m&#233;dicas e suas associa&#231;&#245;es como agentes cr&#237;ticos de mudan&#231;a na abordagem da carga de doen&#231;as cardiovasculares no mundo. </p>
    <p>
      <bold>Delibera&#231;&#245;es</bold>
    </p>
    <p>1. Trabalhar coletivamente em defesa das metas globais* para preven&#231;&#227;o e controle de DNT abrangendo o uso de medicamentos e dos principais fatores de risco (sedentarismo, hipertens&#227;o, ingest&#227;o excessiva de s&#243;dio e de gordura saturada, tabagismo, obesidade, consumo excessivo de &#225;lcool, hipercolesterolemia), para prevenir infarto agudo do mioc&#225;rdio e acidentes vasculares encef&#225;licos<sup>6</sup>. </p>
    <p>2. Implementar pol&#237;ticas p&#250;blicas para preven&#231;&#227;o e controle das DCNT na popula&#231;&#227;o em geral e nos grupos espec&#237;ficos, no Brasil e nas Am&#233;ricas, para atingir a meta global de redu&#231;&#227;o de 25% na mortalidade prematura at&#233; 2025. </p>
    <p>3. Defender coletivamente o controle das DCNT, incluindo-as em discuss&#245;es de f&#243;runs nacionais e internacionais. </p>
    <p>4. Trabalhar em conjunto na redu&#231;&#227;o da mortalidade, morbidade e incapacidade causadas pelas DCNT, por meio de a&#231;&#245;es conjuntas de preven&#231;&#227;o e promo&#231;&#227;o da sa&#250;de, associadas com diagn&#243;stico precoce e tratamento. </p>
    <p>5. Fornecer o mais alto n&#237;vel de educa&#231;&#227;o m&#233;dica continuada e conhecimento cient&#237;fico para os profissionais de aten&#231;&#227;o prim&#225;ria, cardiologistas, enfermeiros intensivistas e outros profissionais de sa&#250;de. </p>
    <p>6. Agir sobre os determinantes sociais que influenciam os fatores de risco para DNT, por meio de pol&#237;ticas governamentais para promover ambientes f&#237;sicos e sociais adequados para a redu&#231;&#227;o da exposi&#231;&#227;o ao risco, facilitando a ado&#231;&#227;o de h&#225;bitos saud&#225;veis por parte da popula&#231;&#227;o, em ambientes escolares, de trabalho e de lazer, espa&#231;os urbanos e outros. </p>
    <p>7. Atuar com os governos para o desenvolvimento e aplica&#231;&#227;o de um programa de preven&#231;&#227;o cardiovascular nos pa&#237;ses, estabelecendo formas de avalia&#231;&#227;o dos resultados junto &#224; popula&#231;&#227;o. </p>
    <p>8. Treinar e qualificar os profissionais de sa&#250;de para o tratamento das emerg&#234;ncias cardiovasculares e encorajar os leigos a obterem t&#233;cnicas e compet&#234;ncias em ressuscita&#231;&#227;o cardiopulmonar utilizando protocolos estabelecidos pelas sociedades cient&#237;ficas. </p>
    <p>9. Desenvolver projetos colaborativos que apoiem a abordagem "curso de vida", que enfatiza a promo&#231;&#227;o da sa&#250;de e estrat&#233;gias de preven&#231;&#227;o para minimizar o risco de DNT, em todos os est&#225;gios da vida. </p>
    <p>10. Mobilizar os meios de comunica&#231;&#227;o para levar informa&#231;&#245;es cont&#237;nuas sobre a import&#226;ncia das doen&#231;as cardiovasculares, seus principais fatores de risco e formas de preven&#231;&#227;o, ampliando a divulga&#231;&#227;o para a popula&#231;&#227;o com o intuito de evitar sua ocorr&#234;ncia e ressaltar a import&#226;ncia do diagn&#243;stico precoce para reduzir a mortalidade. </p>
    <p>11. Implementar a&#231;&#245;es para aquisi&#231;&#227;o de informa&#231;&#227;o epidemiol&#243;gica, incluindo mortalidade e morbidade cardiovascular, execu&#231;&#227;o e manuten&#231;&#227;o de registros j&#225; existentes em alguns dos signat&#225;rios, visando o desenvolvimento de estrat&#233;gias que promovam o planejamento das a&#231;&#245;es de sa&#250;de.</p>
    <p>12. Criar um f&#243;rum internacional de discuss&#227;o permanente para monitorar as a&#231;&#245;es voltadas para preven&#231;&#227;o, diagn&#243;stico e tratamento dos fatores de risco cardiovascular na Am&#233;rica Latina. </p>
    <p>13. Estabelecer campanhas de preven&#231;&#227;o cardiovascular, promovendo esfor&#231;os consistentes para obter a meta de redu&#231;&#227;o de 25% da taxa de mortalidade at&#233; 2025. As campanhas devem envolver os fatores de risco cardiovascular: tabagismo, alimenta&#231;&#227;o inadequada, ingest&#227;o excessiva de s&#243;dio, inatividade f&#237;sica, obesidade, hipertens&#227;o arterial, hipercolesterolemia e diabetes, como especificado nas diretrizes e pela Organiza&#231;&#227;o Mundial de Sa&#250;deWorld Health Organization. </p>
    <p>Este documento foi elaborado com a participa&#231;&#227;o de Carlos Alberto Machado, Daniel Pi&#241;eiro, Donna K. Arnett, Fausto Pinto, Gl&#225;ucia Maria M. Oliveira, Hans F. Dohmann, Jadelson P. Andrade, Luiz Alberto P. Mattos, Sidney C. Smith Jr. e Stephan Gielen. </p>
    <p>As seguintes entidades apoiam e recomendam todos os termos contidos neste documento: Sociedade Brasileira de Cardiologia (SBC), Sociedade Interamericana de Cardiologia (SIAC), American Heart Association (AHA), Sociedade Europeia de Cardiologia (European Society of Cardiology, ESC), Federa&#231;&#227;o Mundial do Cora&#231;&#227;o (World Heart Federation, WHF). </p>
    <p>Assinado pelos presidentes das sociedades de cardiologia: </p>
    <p>
      <bold>Jadelson P. Andrade</bold>
    </p>
    <p> Presidente </p>
    <p> Sociedade Brasileira de Cardiologia</p>
    <p>
      <bold>Daniel Pi&#241;eiro </bold>
    </p>
    <p> Presidente </p>
    <p> Sociedade Interamericana de Cardiologia</p>
    <p>
      <bold>Donna K. Arnett </bold>
    </p>
    <p> Presidente </p>
    <p> American Heart Association </p>
    <p>
      <bold>Fausto Pinto </bold>
    </p>
    <p> Presidente eleito </p>
    <p> European Society of Cardiology</p>
    <p>
      <bold>Sidney C. Smith, Jr </bold>
    </p>
    <p> Presidente </p>
    <p> World Heart Federation</p>
    <p>
      <bold>Refer&#234;ncias</bold>
    </p>
    <p content-type="ref-to-delete">1. World Health Organization. 65th World Health Assembly document A65/54: Second report of Committee A. Published May 25, 2012. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_54-en.pdf">http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_54-en.pdf</ext-link>. Acessado em 4 de novembro de 2012.  </p>
    <p content-type="ref-to-delete">2. World Health Organization, World Heart Federation, World Stroke Organization. Global atlas on cardiovascular disease prevention and control: policies, strategies, and interventions. Published 2011. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/">http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/</ext-link>. Acessado em 4 de novembro de 2012  </p>
    <p content-type="ref-to-delete">3. Plano de a&#231;&#245;es estrat&#233;gicas para o enfrentamento das doen&#231;as cr&#244;nicas n&#227;o transmiss&#237;veis no Brasil, 2011-2022. Minist&#233;rio da Sa&#250;de - Secretaria de Vigil&#226;ncia &#224; Sa&#250;de.  </p>
    <p content-type="ref-to-delete">4. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R Rodgers A. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet. 2007; 370:2054-2062.  </p>
    <p content-type="ref-to-delete">5. Smith SC Jr, Collins A, Ferrari R, Holmes DR Jr, Logstrup S, McGhie DV, Ralston J, Sacco RL, Stam H, Taubert K, Wood DA, Zoghbi WA. Our time: a call to save preventable deaths from cardiovascular disease (heart disease and stroke). Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://circ.ahajournals.org/content/early/2012/09/17/CIR.0b013e318267e99f.citation">http://circ.ahajournals.org/content/early/2012/09/17/CIR.0b013e318267e99f.citation</ext-link>, Acessado em 4 de novembro de 2012.  </p>
    <p> 6. World Health Organization. Revised [third] WHO discussion paper on the development of a comprehensive global monitoring framework, including indicators, and a set of voluntary global targets for the prevention and control of NCDs. Published July 2012. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/nmh/events/2012/ncd_discussion_paper/en/index.html">http://www.who.int/nmh/events/2012/ncd_discussion_paper/en/index.html</ext-link> Acessado em 4 de novembro de 2012.</p>
    <p>Rio de Janeiro, 30 de novembro de 2012 </p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1.	World Health Organization. 65th World Health Assembly document A65/54: Second report of Committee A. Published May 25, 2012. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_54-en.pdf">http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_54-en.pdf</ext-link>. Acessado em 4 de novembro de 2012.</mixed-citation>
        <element-citation publication-type="book">
          <source>65th World Health Assembly document A65/54: Second report of Committee A</source>
          <date>
            <year>2012</year>
            <day>25</day>
            <month>05</month>
          </date>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2.	World Health Organization, World Heart Federation, World Stroke Organization. Global atlas on cardiovascular disease prevention and control: policies, strategies, and interventions. Published 2011. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/">http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/</ext-link>. Acessado em 4 de novembro de 2012</mixed-citation>
        <element-citation publication-type="book">
          <source>Global atlas on cardiovascular disease prevention and control: policies, strategies, and interventions</source>
          <date>
            <year>2011</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3.	Plano de a&#231;&#245;es estrat&#233;gicas para o enfrentamento das doen&#231;as cr&#244;nicas n&#227;o transmiss&#237;veis no Brasil, 2011-2022. Minist&#233;rio da Sa&#250;de - Secretaria de Vigil&#226;ncia &#224; Sa&#250;de.</mixed-citation>
        <element-citation publication-type="book">
          <source>Plano de a&#231;&#245;es estrat&#233;gicas para o enfrentamento das doen&#231;as cr&#244;nicas n&#227;o transmiss&#237;veis no Brasil, 2011-2022</source>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R Rodgers  A.  Prevention  of  cardiovascular  disease  in high-risk  individuals  in low-income and middle-income countries: health effects and costs. Lancet. 2007; 370:2054-2062.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs</article-title>
          <source>Lancet</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2054</fpage>
          <lpage>2062</lpage>
          <volume>370</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Gaziano</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Gakidou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Farzadfar</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lozano</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rodgers</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Smith SC Jr, Collins A, Ferrari R, Holmes DR Jr, Logstrup S, McGhie DV,  Ralston  J,  Sacco RL,  Stam  H,  Taubert K, Wood  DA,  Zoghbi WA.  Our time:  a  call  to  save  preventable  deaths  from  cardiovascular  disease  (heart disease  and  stroke).  Dispon&#237;vel  em: <ext-link ext-link-type="uri" xlink:href="http://circ.ahajournals.org/content/early/2012/09/17/CIR.0b013e318267e99f.citation">http://circ.ahajournals.org/content/early/2012/09/17/CIR.0b013e318267e99f.citation</ext-link>, Acessado  em 4 de novembro de 2012.</mixed-citation>
        <element-citation publication-type="webpage">
          <source>Our time: a call to save preventable deaths from cardiovascular disease (heart disease and stroke)</source>
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>SC Jr</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>DR Jr</given-names>
            </name>
            <name>
              <surname>Logstrup</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McGhie</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Ralston</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sacco</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Stam</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Taubert</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Zoghbi</surname>
              <given-names>WA</given-names>
            </name>
          </person-group>
          <comment>Available at:<ext-link ext-link-type="uri" xlink:href="http://http://circ.ahajournals.org/content/early/2012/09/17/CIR.0b013e318267e99f.citation">link</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="B6">
        <element-citation publication-type="book">
          <source>WHO discussion paper on the development of a comprehensive global monitoring framework, including indicators, and a set of voluntary global targets for the prevention and control of NCDs</source>
          <date>
            <year>2012</year>
            <month>07</month>
          </date>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Editorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Brazilian Society of Cardiology: letter from Rio de Janeiro - III Brazil Prevent / I Latin American Prevent</article-title>
      </title-group>
    </front-stub>
    <body>
      <p>
        <bold>EDITORIAL</bold>
      </p>
      <p>
        <bold>Brazilian Society of Cardiology: letter from Rio de Janeiro - III Brazil Prevent / I Latin American Prevent</bold>
      </p>
      <p>
        <bold>Jadelson P. Andrade; Donna K. Arnett; Fausto Pinto; Daniel Pi&#241;eiro; Sidney C. Smith Jr; Luiz Alberto P. Mattos; Carlos Alberto Machado; Gl&#225;ucia Maria M. Oliveira; Hans F. Dohmann; Stephan Gielen</bold>
      </p>
      <p>
        <bold>Purpose</bold>
      </p>
      <p>The final document will be published as a special article in the Arquivos Brasileiros de Cardiologia and as an editorial note in scientific journals of societies and their affiliates supporting this document</p>
      <p>The document aims to provide an overview of cardiovascular diseases and outline strategic actions to reduce the prevalence of risk factors that contribute to high morbidity and mortality.</p>
      <p>Acknowledging the Political Declaration of the United Nations High-Level Meeting on the Prevention and Control of Non-communicable Diseases (NCD's)<sup>1</sup>.</p>
      <p>Reaffirming the World Health Assembly Decision WHA 65.8 on follow-up to the United Nations High-Level Meeting on the Prevention and Control of NCD's and the adoption of the global target of a 25% reduction in premature mortality from non-communicable diseases by 2025<sup>1</sup>.</p>
      <p>Recognizing that in 2008, 36 million (63%) global deaths were caused by NCDs, 9 million of which occurred under the age of 60 years. Furthermore, almost 80% of the leading chronic diseases (29 million) occurred in low and middle income countries. Cardiovascular diseases will remain the number one global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to &gt; 23.6 million by 2030<sup>2</sup>. In Latin America, 40% of cardiovascular deaths occur during an individual's most productive years<sup>3</sup>.</p>
      <p>In Brazil, NCDs are a health problem of major magnitude, accounting for 72% of death causes, especially cardiovascular diseases (31.3%), cancer (16.3%), diabetes (5.2%) and chronic respiratory diseases (5.8%), affecting individuals of all socioeconomic levels and, more specifically, those belonging to vulnerable groups, such as the elderly and those with low educational level and income<sup>3</sup>.</p>
      <p>It is worth noting that three hundred thousand Brazilians die annually due to cardiovascular diseases, such as infarction, stroke, heart and kidney failure, and sudden death, which means 820 deaths a day, 30 deaths per hour or one death every two minutes<sup>3</sup>.</p>
      <p>It is estimated that beyond the lives saved and the life-years extended, reducing the mortality rate for ischemic heart disease and stroke by 10% would also reduce economic losses in low- and middle-income countries by an estimated US$ 25 billion per year<sup>4,5</sup>.</p>
      <p>The role of leading medical associations and professional societies as critical agents of change in addressing the global burden of cardiovascular diseases and stroke is widely recognized.</p>
      <p>1. To work collectively in advocating all global targets* for the prevention and control of NCDs to cover all major risk factors, such as physical inactivity, hypertension, sodium reduction, tobacco use, saturated fat intake, obesity, alcohol consumption, cholesterol, and drug therapy to prevent heart attacks and strokes<sup>6</sup>;</p>
      <p>2. To strengthen the development and implementation of public policies for the prevention and control of NCDs in the general population and specific population groups in Brazil and in the Americas to reach the global target of a 25% reduction in premature mortality from NCDs by 2025;</p>
      <p>3. To collectively defend the control of NCDs, placing emphasis on these diseases, which should be included in discussions in reputable national and international forums; </p>
      <p>4. To work together to reduce morbidity, disability and mortality caused by NCDs, through a set of preventive and health promotion actions, associated with early detection and treatment;</p>
      <p>5. To provide the highest level of continuing medical education and scientific knowledge to primary care physicians, cardiologists, critical care nurses and other health professionals;</p>
      <p>6. To act on the social determinants that influence risk factors for NCDs, through governmental policies to promote physical and social environments suitable to reduced risk exposure, facilitating the adoption of healthy behaviors by the population, in school environments, work and leisure, urban spaces and others;</p>
      <p>7. Act with the governments seeking for the development and application of a Cardiovascular Prevention Program in the countries and establish ways to gauge the results of this movement along with the population;</p>
      <p>8. Implement coaching and qualification of the health professionals in the treatment of the cardiac emergency and encourage lay people to obtain techniques/ competences in resuscitation using the established protocols by the Scientifics societies;</p>
      <p>9. To develop collaborative projects that support a "life course" approach that emphasizes health promotion and disease prevention strategies to minimize the risk of NCDs, at every stage of life;</p>
      <p>10. Encourage media to continuously inform the public about the importance of cardiovascular diseases, the main factors, prevention forms, enhance public education and communication to have more divulgation with the population about the best way to avoid its occurrence and the importance of early diagnosis to reduce mortality;</p>
      <p>11. Implement actions for the acquisition of epidemiological information, including cardiovascular morbidity and mortality and the execution/maintenance records, existing in some of the signatories, aiming at developing strategies and promoting planning of the health actions;</p>
      <p>12. To create a permanent international forum for discussion, monitoring and implementation of actions aimed for the prevention, diagnosis and treatment of cardiovascular risk factors in Latin America;</p>
      <p>13. Establish cardiovascular prevention campaigns in order to promote consistent efforts to obtain a target reduction of 25% for the mortality rate until 2025. The campaigns should involve 7 cardiovascular risk factors: smoking, poor diet e.g. high salt intake, physical inactivity, obesity, hypertension, high cholesterol and diabetes, as specified by guidelines and WHO.</p>
      <p>This document was prepared with the participation of Carlos Alberto Machado, Daniel Pi&#241;eiro, Donna K. Arnett, Fausto Pinto, Gl&#225;ucia Maria M. Oliveira, Hans F. Dohmann, Jadelson P. Andrade, Luiz Alberto P. Mattos, Sidney C. Smith Jr. and Stephan Gielen.</p>
      <p>The entities listed below support and recommend all terms contained in this document.</p>
      <p>Brazilian Society of Cardiology (BSC), Interamerican Society of Cardiology (SIAC), American Heart Association (AHA), European Society of Cardiology (ESC), and World Heart Federation (WHF).</p>
      <p>Signed by the Presidents of the Cardiology Societies:</p>
      <p>
        <bold>Jadelson P. Andrade</bold>
      </p>
      <p> BSC - President</p>
      <p>
        <bold>Daniel Pi&#241;eiro </bold>
      </p>
      <p> SIAC - President</p>
      <p>
        <bold>Donna K. Arnett </bold>
      </p>
      <p> AHA - President </p>
      <p>
        <bold>Fausto Pinto </bold>
      </p>
      <p> ESC - President-Elect</p>
      <p>
        <bold>Sidney C. Smith, Jr </bold>
      </p>
      <p> WHF - President</p>
      <p>
        <bold>References</bold>
      </p>
      <p content-type="ref-to-delete">1. World Health Organization. 65th World Health Assembly document A65/54: Second report of Committee A. Published May 25, 2012. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_54-en.pdf">http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_54-en.pdf</ext-link>. Acessado em 4 de novembro de 2012.  </p>
      <p content-type="ref-to-delete">2. World Health Organization, World Heart Federation, World Stroke Organization. Global atlas on cardiovascular disease prevention and control: policies, strategies, and interventions. Published 2011. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/">http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/</ext-link>. Acessado em 4 de novembro de 2012  </p>
      <p content-type="ref-to-delete">3. Plano de a&#231;&#245;es estrat&#233;gicas para o enfrentamento das doen&#231;as cr&#244;nicas n&#227;o transmiss&#237;veis no Brasil, 2011-2022. Minist&#233;rio da Sa&#250;de - Secretaria de Vigil&#226;ncia &#224; Sa&#250;de.  </p>
      <p content-type="ref-to-delete">4. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R Rodgers A. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet. 2007; 370:2054-2062.  </p>
      <p>5. Smith SC Jr, Collins A, Ferrari R, Holmes DR Jr, Logstrup S, McGhie DV, Ralston J, Sacco RL, Stam H, Taubert K, Wood DA, Zoghbi WA. Our time: a call to save preventable deaths from cardiovascular disease (heart disease and stroke). Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://circ.ahajournals.org/content/early/2012/09/17/CIR.0b013e318267e99f.citation">http://circ.ahajournals.org/content/early/2012/09/17/CIR.0b013e318267e99f.citation</ext-link>, Acessado em 4 de novembro de 2012.      </p>
      <p>Rio de Janeiro, November 30<sup>th</sup>, 2012</p>
    </body>
  </sub-article>
</article>
